ReviewFrontiers in medicine2016
Focus on Alectinib and Competitor Compounds for Second-Line Therapy in
Phu N Tran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewFrontiers in medicine2016
Phu N Tran et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.